X
Credit:
Roswell Park’s Saby George, MD, will present findings of a large international study in patients with kidney cancer showing that the immunotherapy nivolumab can be given effectively as a subcutaneous injection.
« Subcutaneous Nivolumab as Effective as IV for Renal Cell Carcinoma — With Much Faster Treatment Time